19.02.2015 • NewsDede WillamsChris ViehbacherSanofi

Bayer’s Brandicourt Could Be New Sanofi CEO

As the search narrows for a successor to Chris Viehbacher, who was dismissed last year as CEO of French drugmaker Sanofi, French newspaper Le Figaro has identified Bayer HealthCare head Oliver Brandicourt as the most likely candidate.

The name Brandicourt also has been circulating in pharmaceutical industry circles as a possible replacement. Currently, Sanofi is being managed by supervisory board chairman Serge Weinberg.

It was Weinberger who took responsibility for the October 2014 abrupt dismissal of Viehbacher, the company's first non-French CEO, with whom he disagreed on communications strategy.

Brandicourt, a physician who has headed the Bayer business since 2013, previously worked for Pfizer. Prior to that, he was engaged in malaria research, in France and elsewhere.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.